HIF1A and ovarian benign neoplasm: To determine whether LOX and HIF-1α expression increases in ovarian cancer tissues, we examined the expression of LOX and HIF-1α in 44 cases of human epithelial ovarian carcinoma, 20 cases of borderline ovarian tumor, 27 cases of benign ovarian tumor and 28 cases of normal ovarian tissues.